Argitalpenak (9) KARINA OVEJERO PAREDES argitalpenak

2024

  1. Albumin-Loaded Silica Nanomaterials Functionalized with Organotin(IV) Agents: Theranostic Materials Against Triple-Negative Breast Cancer

    Advanced Therapeutics

  2. Amino acid-decorated mesoporous silica nanoparticles loaded with titanocene derivatives for targeted anticancer studies

    Applied Organometallic Chemistry, Vol. 38, Núm. 6

  3. Vanadocene-functionalized mesoporous silica nanoparticles: platforms for the development of theranostic materials against breast cancer

    Biomedical Materials (Bristol), Vol. 19, Núm. 3

2023

  1. Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug

    Pharmaceutics, Vol. 15, Núm. 2

  2. Organotin(IV)-Decorated Graphene Quantum Dots as Dual Platform for Molecular Imaging and Treatment of Triple Negative Breast Cancer

    Chemistry - A European Journal, Vol. 29, Núm. 60

2022

  1. NIL10: A New IL10-Receptor Binding Nanoparticle That Induces Cardiac Protection in Mice and Pigs Subjected to Acute Myocardial Infarction through STAT3/NF-κB Activation

    Pharmaceutics, Vol. 14, Núm. 10

  2. Synthesis of a theranostic platform based on fibrous silica nanoparticles for the enhanced treatment of triple-negative breast cancer promoted by a combination of chemotherapeutic agents

    Biomaterials Advances, Vol. 137

  3. Theranostic Contribution of Extracellular Matrix Metalloprotease Inducer-Paramagnetic Nanoparticles Against Acute Myocardial Infarction in a Pig Model of Coronary Ischemia-Reperfusion

    Circulation. Cardiovascular imaging, Vol. 15, Núm. 6, pp. e013379

2018

  1. Hybrid Decorated Core@Shell Janus Nanoparticles as a Flexible Platform for Targeted Multimodal Molecular Bioimaging of Cancer

    ACS Applied Materials and Interfaces, Vol. 10, Núm. 37, pp. 31032-31043